Inventory increased 47.3%
Inventory changed +47.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +47.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed -24.8% from the comparable as-filed period.
Operating income changed -39.3% from the comparable as-filed period.
Operating margin changed -2201 basis points from the comparable as-filed period.
Research & development changed +22.0% from the comparable as-filed period.
Stock-based compensation changed -28.6% from the comparable as-filed period.
Cash & equivalents changed -17.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Revenue changed -3.1% from the comparable as-filed period.
Selling, general & administrative changed +2.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.